IP Library Granted Patent US 8,628,917
Granted Patent B2
US 8,628,917 · App. 13/553,006 · Granted Jan 14, 2014

Genes of an otitis media isolate of nontypeable

Inventors: Lauren O. Bakaletz (Hilliard, OH); Robert S. Munson, Jr. (Columbus, OH); David W. Dyer (Oklahoma City, OK)
Assignees: Nationwide Children's Hospital, Inc.; The Board of Regents of the University of Oklahoma; Children's Hosptial Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,628,917
App. No.
13/553,006
Granted
Jan 14, 2014
Kind
B2
Abstract

The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and/or the nasopharynx.

Claims (8)

1. A method for detecting NTHi bacteria in a biological sample comprising

(a) contacting an isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO: 633 with polynucleotides from a biological sample under stringent hybridization conditions, wherein the hybridization conditions comprise washing with 0.015 M sodium chloride, 0.0015 M sodium citrate at 65-68° C. , and

(b) detecting hybridization of the polynucleotide within the sample, wherein hybridization indicates the presence of NTHi bacteria in the biological sample.

2. The method of claim 1 wherein the biological sample is selected from the group consisting of serum, sputum, ear fluid, blood, urine, lymphatic fluid, and cerebrospinal fluid.

3. A vector comprising an isolated polynucleotide comprising the nucleotide sequence of SEQ ID NO: 633.

4. A vector, wherein an isolated polynucleotide comprising the nucleotide of SEQ ID NO: 663 is operatively linked to an expression control sequence.

5. An isolated cell comprising the vector of claim 3 .

6. A host cell comprising the vector of claim 4 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2012
From: BAKALETZ, LAUREN O.; MUNSON, ROBERT S., JR.
To: CHILDREN'S HOSPITAL, INC.
Reel/Frame 029001/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2012
From: DYER, DAVID W.
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
Reel/Frame 029001/0620 →
CHANGE OF NAME Recorded Sep 21, 2012
From: CHILDREN'S HOSPITAL, INC.
To: NATIONWIDE CHILDREN'S HOSPITAL, INC.
Reel/Frame 029027/0107 →
Continuity (7)
Division 13187989 · Jul 21, 2011
Division 12860332 · Aug 20, 2010
Division 12646424 · Dec 23, 2009
Continuation 11770447 · Jun 28, 2007
Continuation 10795159 · Mar 5, 2004
Provisional Application 60453134 · Mar 6, 2003
Related Publication 20130017204A1 · Jan 17, 2013